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fication of three fatal cases of human infection with a novel
avian influenza A (H7N9) virus during February and March
2013.1 This novel H7N9 virus has never been identified in
humans or animals before. This astonishing news has raised
global public health concerns2 and triggered the Taiwan
Centers for Disease Control (Taiwan CDC) to immediately
respond to this emerging disease, including designating
H7N9 influenza as a notifiable disease, developing an in-
house real-time reverse transcription-polymerase chain
reaction (RT-PCR) assay, and activating the Central
Epidemic Command Center (CECC) for coordinating inter-
departmental efforts against the H7N9 outbreak in China.
As of May 2, China has reported 127 laboratory-confirmed
cases of human infection with H7N9 virus (including 26
deaths) from eight provinces and two cities. In Taiwan,
Taiwan CDC detected an imported case, who is the only
single case outside Mainland China (Fig. 1).3,4 The current
evidence suggests that live poultry markets probably play a
key role for transmitting the virus from poultry to humans.5
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clusters were identified where limited human-to-human
transmission cannot be ruled out.6
In contrast to highly pathogenic avian influenza (HPAI)
H5N1 viruses causing severe diseases in infected chickens,
H7N9 viruses are a low-pathogenic avian influenza A virus
resulting in silent transmission in poultry. It will be very
difficult to detect H7N9 virus from the asymptomatic but
infected poultry and sporadic human cases caused by the
H7N9 virus may occur time and time again. Because the
spread of the global H5N1 outbreaks were highly correlated
with the patterns of migration of wild birds,7 they may also
play an important role in spreading H7N9 from China to
Taiwan and other countries later. In Fig. 1, the generalized
migration routes denote the East Asia Australian flyway,
which is one of the eight broadly grouped flyways of wa-
terbirds in the world. The asymptomatic waterbirds infec-
ted by the H7N9 virus may follow the autumn migration
routes to visit Taiwan from Jiangsu and Zhejiang provinces
this fall. The infected waterbirds may spread the virus to
domestic poultry farms in Taiwan. For this reason, the CECC
has decided to permanently ban the killing of live poultry in
traditional markets in Taiwan from May 17, 2013 onwards.
The genetic sequences also imply that these viruses may
have some signs of adaptation to growth in mammalian
species. These adaptations include an ability to bind to& Formosan Medical Association. All rights reserved.
Figure 1 Spatial distributions of human infections with avian influenza A(H7N9) virus and generalized migration routes of the East
Asia Australian flyway.
300 H.-S. Wu et al.mammalian cells with the amino acid Q226L mutation in the
HA protein, and to grow at temperatures close to the
normal body temperature of mammals with the amino acid
E627K mutation in the PB2 protein.8 In addition, both Q226L
and E627K mutations were associated with respiratory
transmission of the HPAI H5N1 virus in ferrets9; therefore, it
raises the possibility of avian-to-human to human-to-human
transmission. Regarding the antiviral agents, the viral
sequence data indicate resistance to amantadine with an
amino acid change in the M2 protein (S31N), but suscepti-
bility to neuraminidase inhibitors with the amino acid
Arginine (R) at position 292 in the NA protein, except for an
R292K mutation in A/Shanghai/1/2013 virus. According to
the sequence data for NA gene of the H7N9 virus isolated
from the first case in Taiwan, a mix pattern of both arginine
(R) and lysine (K) residues occurring at position 292 in the
NA protein was noted. Whether this mutation is associated
with oseltamivir treatment and what is the proportion of all
resistant strains to this antiviral agent may need further
analysis.
Since closing the live poultry markets in Shanghai on April
5, the incidence of human cases caused by H7N9 virus has
been dramatically decreasing. However, the H7N9 virus may
spread silently in poultry in China and spread globallythrough the migration of wild birds. At the current stage,
intensified surveillance for H7N9 virus in wild birds, poultry
and humans, especially for those with severe pneumonia of
unknown etiology, is extremely important. In addition, there
is a need to conduct seroprevalence studies to determine
whether people have cross-reactive antibodies to these vi-
ruses from prior influenza infections or vaccinations. These
data will be helpful for us to estimate how many asymp-
tomatic or mild cases infected by this virus, understand the
mode of transmission, and instigate proper control measures
as well. Finally, many influenza experts, such as Dr. Nancy
Cox of the Centers for Disease Control and Prevention in the
USA (USCDC), have expressed their concerns on the
pandemic potential of the H7N9 virus.2 We should cooperate
with the World Health Organization, USCDC, researchers,
manufacturers, etc. to develop H7N9 vaccines and prove its
safety and effectiveness through clinical trials10 to prepare
for the potential pandemic influenza.
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